Pharma CDMO & Services
Contract development & manufacturing for global pharma — IP-led.
China+1 sourcing reshuffle directing global pharma to Indian CDMOs for APIs, intermediates and complex molecules. IP-led, export-driven and currency-sensitive.
7-day basket return of 61 member stocks. Real OHLCV.